KCNJ10
ATP-sensitive inward rectifier potassium channel 10
Also known as: KCJ10_HUMAN, Kir1.2, Kir4.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P78508
- Gene
- KCNJ10
- Ensembl
- ENSG00000177807
- Chromosome
- 1
- Canonical length
- 379 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the inward rectifier-type potassium channel family, characterized by having a greater tendency to allow potassium to flow into, rather than out of, a cell. The encoded protein may form a heterodimer with another potassium channel protein and may be responsible for the potassium buffering action of glial cells in the brain. Mutations in this gene have been associated with seizure susceptibility of common idiopathic generalized epilepsy syndromes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
379 residues, UniProt reviewed canonical sequence.
>P78508|KCNJ10
1 MTSVAKVYYS QTTQTESRPL MGPGIRRRRV LTKDGRSNVR MEHIADKRFL YLKDLWTTFI
61 DMQWRYKLLL FSATFAGTWF LFGVVWYLVA VAHGDLLELD PPANHTPCVV QVHTLTGAFL
121 FSLESQTTIG YGFRYISEEC PLAIVLLIAQ LVLTTILEIF ITGTFLAKIA RPKKRAETIR
181 FSQHAVVASH NGKPCLMIRV ANMRKSLLIG CQVTGKLLQT HQTKEGENIR LNQVNVTFQV
241 DTASDSPFLI LPLTFYHVVD ETSPLKDLPL RSGEGDFELV LILSGTVEST SATCQVRTSY
301 LPEEILWGYE FTPAISLSAS GKYIADFSLF DQVVKVASPS GLRDSTVRYG DPEKLKLEES
361 LREQAEKEGS ALSVRISNVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNJ10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 114 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 114 nTPM
- basal ganglia: 69 nTPM
- cerebral cortex: 68 nTPM
- midbrain: 66 nTPM
- amygdala: 56 nTPM
- hippocampal formation: 52 nTPM
Single-cell type
- epicardial cells: 125 nCPM
- oligodendrocytes: 110 nCPM
- astrocytes: 107 nCPM
- bergmann glia: 88 nCPM
- müller glia: 87 nCPM
- oligodendrocyte progenitor cells: 61 nCPM
Immune cell
- T-reg: 0.6 nTPM
- naive CD8 T-cell: 0.4 nTPM
- NK-cell: 0.4 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebellum: 208 nTPM
- white matter: 202 nTPM
- midbrain: 195 nTPM
- medulla oblongata: 193 nTPM
- basal ganglia: 174 nTPM
- thalamus: 172 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNJ10.
Disease | AllUniProt
Conditions KCNJ10 is implicated in, by any mechanism.
- Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) MIM:612780
Disease | GeneticClinVar
32 pathogenic / likely-pathogenic of 453 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- EAST syndrome
- Autosomal recessive nonsyndromic hearing loss 4
- Pendred syndrome
- SeSAME-like syndrome
- Microcephaly
Disease | AutoantibodyPubMed
Conditions in which antibodies against KCNJ10 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for KCNJ10 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
11 publications
- Potassium channel KIR4.1 as an immune target in multiple sclerosis.
2012 · N Engl J Med · RCR 7.7 · 265 citations - Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
2014 · Lancet Neurol · RCR 2.3 · 69 citations - Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
2014 · Neurology · RCR 1.4 · 44 citations - Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
2014 · Mult Scler · RCR 1.3 · 41 citations - Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?
2015 · Mult Scler · RCR 1 · 27 citations
Show 6 more
- KIR4.1: K+ Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis.
2016 · Front Mol Neurosci · RCR 0.6 · 15 citations - Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.
2020 · Int J Mol Sci · RCR 0.5 · 10 citations - Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.
2016 · Neurol Neuroimmunol Neuroinflamm · RCR 0.5 · 14 citations - Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
2017 · PLoS One · RCR 0.5 · 13 citations - Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.
2017 · J Immunol Methods · RCR 0.4 · 10 citations - Anti-KIR4.1 Antibodies in Chinese Patients with Central Nervous System Inflammatory Demyelinating Disorders.
2016 · Neuroimmunomodulation · RCR 0.1 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0.15
- gnomAD missense Z
- 1.48
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult walking behavior
- cellular response to potassium ion
- central nervous system myelination
- glutamate reuptake
- non-motile cilium assembly
- potassium ion homeostasis
- potassium ion import across plasma membrane
- potassium ion transmembrane transport
- potassium ion transport
- regulation of long-term neuronal synaptic plasticity
- regulation of monoatomic ion transmembrane transport
- regulation of resting membrane potential
- visual perception
Molecular functions
- ATP binding
- ATP-activated inward rectifier potassium channel activity
- inward rectifier potassium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Potassium channel, inwardly rectifying, Kir, cytoplasmic
- Immunoglobulin E-set
- Potassium channel, inwardly rectifying, Kir
- Potassium channel, inwardly rectifying, transmembrane domain
- Inward rectifier potassium channel, C-terminal
- Inward rectifier potassium channel transmembrane domain
- Inward rectifier potassium channel C-terminal domain
- Potassium channel, inwardly rectifying, Kir1.2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNJ10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNJ10 as an antibody target. Whether an autoantibody or antibody against KCNJ10 could matter depends on whether native KCNJ10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNJ10 is annotated at the cell surface, where native KCNJ10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNJ10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...